Puma Biotechnology | Revenu Net



Net Income Changement Date
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Daiichi Sankyo JPY 87.15B 25.22B 2025-03
Exelixis USD 159.62M 19.76M 2025-04
Gilead Sciences USD 1.78B 529M 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 158.2M 43.01M 2025-03
MacroGenics USD -15421000 71.73M 2024-12
Moderna USD -971000000 149M 2025-03
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Takeda JPY -103155000000 126.94B 2025-03
TG Therapeutics USD 23.33M 19.45M 2024-12
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Puma Biotechnology Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.